Le SIDA au Ghana (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Performance characteristics of a new rapid immunochromatographic test for the detection of antibodies to human immunodeficiency virus (HIV) types 1 and 2

Identifieur interne : 000B79 ( Main/Exploration ); précédent : 000B78; suivant : 000B80

Performance characteristics of a new rapid immunochromatographic test for the detection of antibodies to human immunodeficiency virus (HIV) types 1 and 2

Auteurs : H. Syed Iqbal [Inde] ; P. Balakrishnan [Inde] ; K. G. Murugavel [Inde] ; Solomon Suniti [Inde]

Source :

RBID : ISTEX:5F6CFE7D3CB68C5CF0F986387B7ED568224CDCC4

English descriptors

Abstract

Diagnostic kits for the detection of human immunodeficiency virus (HIV) antibodies have reached an unprecedented number. But choice of an ideal, cost‐effective, and rapid test for HIV infection is of immense value for use in developing countries like India, where resources are limited. In this study we have evaluated the performance characteristics of the rapid immunochromatographic HIV test kit First Response HIV 1‐2.O. First, the laboratory archived 450 characterized plasma/serum specimens, which were tested on First Response HIV 1‐2.O. Second, a total of 134 consecutive voluntary counseling and testing (VCT) specimens were also tested and positive specimens were further confirmed with HIV TRI‐DOT. All these VCT specimens were cross‐checked with HIV double‐enzyme‐linked immunosorbent assay (ELISA) (Murex and Vironostika), and the results were matched. The sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and efficiency of First Response HIV 1‐2.O with the 450 characterized specimens was 100% for HIV‐1 with reference assay. The results in the VCT algorithm were correlating with double‐ELISA. In the HIV‐2 analysis, five HIV‐2‐positive specimens in First Response HIV 1‐2.O were found to be HIV‐2‐indeterminate on Western blot. HIV TRI‐DOT was unable to pick up two HIV‐2 Western blot–positive specimens. First Response HIV 1‐2.O has several advantages: low‐cost (U.S. $0.70); only 10 µL of specimen; involves only two steps; room temperature storage; ability to differentiate HIV‐1 and 2; and use of whole blood specimen. Hence this test kit could be suitable for initial screening in the HIV testing algorithm in resource‐limited settings. J. Clin. Lab. Anal. 22:178–185, 2008. © 2008 Wiley‐Liss, Inc.

Url:
DOI: 10.1002/jcla.20238


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Performance characteristics of a new rapid immunochromatographic test for the detection of antibodies to human immunodeficiency virus (HIV) types 1 and 2</title>
<author>
<name sortKey="Syed Iqbal, H" sort="Syed Iqbal, H" uniqKey="Syed Iqbal H" first="H." last="Syed Iqbal">H. Syed Iqbal</name>
</author>
<author>
<name sortKey="Balakrishnan, P" sort="Balakrishnan, P" uniqKey="Balakrishnan P" first="P." last="Balakrishnan">P. Balakrishnan</name>
</author>
<author>
<name sortKey="Murugavel, K G" sort="Murugavel, K G" uniqKey="Murugavel K" first="K. G." last="Murugavel">K. G. Murugavel</name>
</author>
<author>
<name sortKey="Suniti, Solomon" sort="Suniti, Solomon" uniqKey="Suniti S" first="Solomon" last="Suniti">Solomon Suniti</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:5F6CFE7D3CB68C5CF0F986387B7ED568224CDCC4</idno>
<date when="2008" year="2008">2008</date>
<idno type="doi">10.1002/jcla.20238</idno>
<idno type="url">https://api.istex.fr/document/5F6CFE7D3CB68C5CF0F986387B7ED568224CDCC4/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000585</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000585</idno>
<idno type="wicri:Area/Istex/Curation">000585</idno>
<idno type="wicri:Area/Istex/Checkpoint">000275</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000275</idno>
<idno type="wicri:doubleKey">0887-8013:2008:Syed Iqbal H:performance:characteristics:of</idno>
<idno type="wicri:Area/Main/Merge">000C02</idno>
<idno type="wicri:Area/Main/Curation">000B79</idno>
<idno type="wicri:Area/Main/Exploration">000B79</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Performance characteristics of a new rapid immunochromatographic test for the detection of antibodies to human immunodeficiency virus (HIV) types 1 and 2</title>
<author>
<name sortKey="Syed Iqbal, H" sort="Syed Iqbal, H" uniqKey="Syed Iqbal H" first="H." last="Syed Iqbal">H. Syed Iqbal</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Inde</country>
<wicri:regionArea>YRG Centre for AIDS Research and Education (YRG CARE), Voluntary Health Services Hospital Campus, Chennai</wicri:regionArea>
<wicri:noRegion>Chennai</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Balakrishnan, P" sort="Balakrishnan, P" uniqKey="Balakrishnan P" first="P." last="Balakrishnan">P. Balakrishnan</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Inde</country>
<wicri:regionArea>YRG Centre for AIDS Research and Education (YRG CARE), Voluntary Health Services Hospital Campus, Chennai</wicri:regionArea>
<wicri:noRegion>Chennai</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<country xml:lang="fr">Inde</country>
<wicri:regionArea>YRG Centre for AIDS Research and Education, Voluntary Health Services campus, IT Corridor, Taramani, Chennai – 600 113</wicri:regionArea>
<wicri:noRegion>Chennai – 600 113</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Murugavel, K G" sort="Murugavel, K G" uniqKey="Murugavel K" first="K. G." last="Murugavel">K. G. Murugavel</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Inde</country>
<wicri:regionArea>YRG Centre for AIDS Research and Education (YRG CARE), Voluntary Health Services Hospital Campus, Chennai</wicri:regionArea>
<wicri:noRegion>Chennai</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Suniti, Solomon" sort="Suniti, Solomon" uniqKey="Suniti S" first="Solomon" last="Suniti">Solomon Suniti</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Inde</country>
<wicri:regionArea>YRG Centre for AIDS Research and Education (YRG CARE), Voluntary Health Services Hospital Campus, Chennai</wicri:regionArea>
<wicri:noRegion>Chennai</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j" type="main">Journal of Clinical Laboratory Analysis</title>
<title level="j" type="alt">JOURNAL OF CLINICAL LABORATORY ANALYSIS</title>
<idno type="ISSN">0887-8013</idno>
<idno type="eISSN">1098-2825</idno>
<imprint>
<biblScope unit="vol">22</biblScope>
<biblScope unit="issue">3</biblScope>
<biblScope unit="page" from="178">178</biblScope>
<biblScope unit="page" to="185">185</biblScope>
<biblScope unit="page-count">8</biblScope>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2008">2008</date>
</imprint>
<idno type="ISSN">0887-8013</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0887-8013</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Aids research</term>
<term>Algorithm</term>
<term>Anal</term>
<term>Assay</term>
<term>Biomed industries</term>
<term>Blot</term>
<term>Card test</term>
<term>Card test assay</term>
<term>Clin</term>
<term>Clin diagn</term>
<term>Clin microbiol</term>
<term>Comparative results</term>
<term>Different antigenic bases</term>
<term>Drug resistance mutations</term>
<term>Elisa</term>
<term>First response</term>
<term>Genetic systemstm</term>
<term>High sensitivity</term>
<term>Human virus</term>
<term>Human virus type</term>
<term>Indeterminate results</term>
<term>Initial screening</term>
<term>Laboratory infrastructure</term>
<term>Microbiol</term>
<term>Nations programme</term>
<term>Negative result</term>
<term>Performance characteristics</term>
<term>Positive specimens</term>
<term>Primary assay</term>
<term>Rapid assay</term>
<term>Rapid assays</term>
<term>Rapid detection</term>
<term>Rapid immunochromatographic test</term>
<term>Reference laboratories</term>
<term>Reliable results</term>
<term>Rural areas</term>
<term>Screening</term>
<term>Screening assays</term>
<term>Second assay</term>
<term>Seronegative specimens</term>
<term>Several advantages</term>
<term>Syed iqbal</term>
<term>Tamil nadu</term>
<term>Testing algorithm</term>
<term>Testing technologies</term>
<term>Voluntary counseling</term>
<term>Western blot</term>
<term>World health organization</term>
</keywords>
<keywords scheme="Teeft" xml:lang="en">
<term>Aids research</term>
<term>Algorithm</term>
<term>Anal</term>
<term>Assay</term>
<term>Biomed industries</term>
<term>Blot</term>
<term>Card test</term>
<term>Card test assay</term>
<term>Clin</term>
<term>Clin diagn</term>
<term>Clin microbiol</term>
<term>Comparative results</term>
<term>Different antigenic bases</term>
<term>Drug resistance mutations</term>
<term>Elisa</term>
<term>First response</term>
<term>Genetic systemstm</term>
<term>High sensitivity</term>
<term>Human virus</term>
<term>Human virus type</term>
<term>Indeterminate results</term>
<term>Initial screening</term>
<term>Laboratory infrastructure</term>
<term>Microbiol</term>
<term>Nations programme</term>
<term>Negative result</term>
<term>Performance characteristics</term>
<term>Positive specimens</term>
<term>Primary assay</term>
<term>Rapid assay</term>
<term>Rapid assays</term>
<term>Rapid detection</term>
<term>Rapid immunochromatographic test</term>
<term>Reference laboratories</term>
<term>Reliable results</term>
<term>Rural areas</term>
<term>Screening</term>
<term>Screening assays</term>
<term>Second assay</term>
<term>Seronegative specimens</term>
<term>Several advantages</term>
<term>Syed iqbal</term>
<term>Tamil nadu</term>
<term>Testing algorithm</term>
<term>Testing technologies</term>
<term>Voluntary counseling</term>
<term>Western blot</term>
<term>World health organization</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Diagnostic kits for the detection of human immunodeficiency virus (HIV) antibodies have reached an unprecedented number. But choice of an ideal, cost‐effective, and rapid test for HIV infection is of immense value for use in developing countries like India, where resources are limited. In this study we have evaluated the performance characteristics of the rapid immunochromatographic HIV test kit First Response HIV 1‐2.O. First, the laboratory archived 450 characterized plasma/serum specimens, which were tested on First Response HIV 1‐2.O. Second, a total of 134 consecutive voluntary counseling and testing (VCT) specimens were also tested and positive specimens were further confirmed with HIV TRI‐DOT. All these VCT specimens were cross‐checked with HIV double‐enzyme‐linked immunosorbent assay (ELISA) (Murex and Vironostika), and the results were matched. The sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and efficiency of First Response HIV 1‐2.O with the 450 characterized specimens was 100% for HIV‐1 with reference assay. The results in the VCT algorithm were correlating with double‐ELISA. In the HIV‐2 analysis, five HIV‐2‐positive specimens in First Response HIV 1‐2.O were found to be HIV‐2‐indeterminate on Western blot. HIV TRI‐DOT was unable to pick up two HIV‐2 Western blot–positive specimens. First Response HIV 1‐2.O has several advantages: low‐cost (U.S. $0.70); only 10 µL of specimen; involves only two steps; room temperature storage; ability to differentiate HIV‐1 and 2; and use of whole blood specimen. Hence this test kit could be suitable for initial screening in the HIV testing algorithm in resource‐limited settings. J. Clin. Lab. Anal. 22:178–185, 2008. © 2008 Wiley‐Liss, Inc.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Inde</li>
</country>
</list>
<tree>
<country name="Inde">
<noRegion>
<name sortKey="Syed Iqbal, H" sort="Syed Iqbal, H" uniqKey="Syed Iqbal H" first="H." last="Syed Iqbal">H. Syed Iqbal</name>
</noRegion>
<name sortKey="Balakrishnan, P" sort="Balakrishnan, P" uniqKey="Balakrishnan P" first="P." last="Balakrishnan">P. Balakrishnan</name>
<name sortKey="Balakrishnan, P" sort="Balakrishnan, P" uniqKey="Balakrishnan P" first="P." last="Balakrishnan">P. Balakrishnan</name>
<name sortKey="Murugavel, K G" sort="Murugavel, K G" uniqKey="Murugavel K" first="K. G." last="Murugavel">K. G. Murugavel</name>
<name sortKey="Suniti, Solomon" sort="Suniti, Solomon" uniqKey="Suniti S" first="Solomon" last="Suniti">Solomon Suniti</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaGhanaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000B79 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000B79 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    SidaGhanaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:5F6CFE7D3CB68C5CF0F986387B7ED568224CDCC4
   |texte=   Performance characteristics of a new rapid immunochromatographic test for the detection of antibodies to human immunodeficiency virus (HIV) types 1 and 2
}}

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Tue Nov 7 18:07:38 2017. Site generation: Tue Mar 5 15:01:57 2024